Download presentation
Presentation is loading. Please wait.
1
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi: 10.1542/peds.2014-1383. Available at: http://pediatrics.aappublications.org/content/early/2014/07/23/peds.2014-1383. TABLE 1 Licensed Meningococcal Vaccines: United States, 1981--2013.
2
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi: 10.1542/peds.2014-1383. Available at: http://pediatrics.aappublications.org/content/early/2014/07/23/peds.2014-1383. TABLE 2 Children at Increased Risk for Meningococcal Disease.
3
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi: 10.1542/peds.2014-1383. Available at: http://pediatrics.aappublications.org/content/early/2014/07/23/peds.2014-1383. TABLE 2 Recommended Meningococcal Vaccines by Age Group.
4
American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi: 10.1542/peds.2014-1383. Available at: http://pediatrics.aappublications.org/content/early/2014/07/23/peds.2014-1383. TABLE 4 Schedule for Booster Doses in Individuals Who Have Persistent Increase Risk for Invasive Meningococcal Disease.
Similar presentations
